CBC is a non-intoxicating cannabinoid. Unlike THC, it does not induce a euphoric high. Instead, it inhibits the uptake of anandamide by cancer cells. It also inhibits the growth of new cancer cells. So, what is CBC isolate used for? Read on to find out. To understand how CBC works, you can visit here that is helpful to know a little about its pharmacology.
CBC is a non-intoxicating cannabinoid:
Cannabichromene (CBC) is a non-intoxicating cannabinoid that shows promise in addressing various medical conditions. CBC has been shown to inhibit pain-related activity and inflammation in animals and is likely to support the body’s endocannabinoid system. It has been shown to reduce inflammation and pain response in patients with osteoarthritis.
CBC is a non-intoxicated cannabinoid produced in the first flowering stage of a cannabis plant. Studies show that it may interact with CB2 cannabinoid receptors in the body, primarily found in the immune system. CBC also binds to transient receptor potential channels, which support a wide range of critical bodily functions. More research is needed before its full potential can be determined.
CBC appears to support the body’s natural ability to regenerate nerve cells. CBC promotes the production of neural stem progenitor cells, which are vital for maintaining the brain’s homeostasis. Furthermore, CBC may aid in preventing neurodegenerative conditions such as Alzheimer’s disease. Its effects on the body are not yet fully understood, but these findings are encouraging.
CBC was first studied in 2006 and was included in a study on the antimicrobial and modulatory effects of cannabinoids. Since then, CBC research has accelerated, reaching the highest concentration over the last three years. It has yet to become mainstream. But with more research, it may soon be used as a therapeutic agent for various ailments. This compound has many uses, including pain relief.
CBC inhibits the uptake of anandamide:
CBC is a ketone body that inhibits anandamide uptake from the brain. The effect of CBC was assessed in mice. In addition to inhibiting anandamide uptake, CBC significantly reduced the contractions induced by anandamide in mice. This was more than double the inhibitory effect of a control compound. However, it is unclear whether CBC is a helpful therapeutic agent or a mere dietary supplement.
CBC can help fight depression and is believed to increase the viability of developing brain cells. Research suggests that it can inhibit the growth of cancerous tumors. Inhibiting anandamide uptake in the body makes CBC a very effective anti-cancer drug. By inhibiting anandamide’s uptake, it remains in the bloodstream for longer. CBC also inhibits the uptake of anandamide, an important endocannabinoid.
In a further study, CBC isolated from croton oil reduced anandamide and palmitoylethanolamide levels in the gut. It also increased CB1 and CB2 receptors. Moreover, it decreased intestinal motility. Furthermore, the treatment inhibited anandamide uptake in mice treated with croton oil. Moreover, CBC inhibited the uptake of croton oil-induced hypermotility in mice.
CBC inhibits the growth of new cancer cells:
One of the essential properties of a CBC isolate is its ability to inhibit the growth of new cancer cells. CBCs actively cycle the crypt-villus axis and continuously contribute to newly generated epithelial cells. In addition, numerous CBC markers of CBCs that overlap with the population of Lgr5+ cells. These markers include B lymphoma mo-MLV insertion region one homolog (Bmi1), HOPx, SPARC-related modular calcium binding 2 (Smoc2), and Lrig1.
The organ of origin determines the plasticity of CRC cells. The tumor niches in different organs are distinct, affecting the extent of CRC cell plasticity. Furthermore, stochastic phenotypic state switching events can inhibit anti-CRC therapy. CBC isolate inhibits the growth of new cancer cells by targeting the Wnthigh tumor cell niche. This suggests that treating Wnthigh cancer cells can target CRC cells for liver metastasis.